Maxillofac Plast Reconstr Surg.  2017 Sep;39(9):27. 10.1186/s40902-017-0126-0.

Hypoglossal nerve stimulation for treatment of obstructive sleep apnea (OSA): a primer for oral and maxillofacial surgeons

• Hong SO
• Chen YF
• Jung J
• Kwon YD
• Liu SY

• KMID: 2395277
• DOI: http://doi.org/10.1186/s40902-017-0126-0

Abstract

The prevalence of obstructive sleep apnea (OSA) is estimated to be 1-5% of the adult population world-wide, and in Korea, it is reported at 4.5% of men and 3.2% of women (Age 40 to 69 years old). Active treatment of OSA is associated with decrease in insulin resistance, cardiovascular disease, psychosocial problems, and mortality. Surgical treatment of OSA has evolved in the era of neuromodulation with the advent of hypoglossal nerve stimulation (HGNS). We share this review of HGNS with our maxillofacial surgical colleagues to expand the scope of surgical care for OSA.

Keyword

Hypoglossal nerve; Upper airway stimulation; Obstructive sleep apnea; Snoring; Sleep endoscopy; OSA surgical treatment; Oral and maxillofacial surgeon

MeSH Terms

Adult
Cardiovascular Diseases
Female
Humans
Hypoglossal Nerve*
Insulin Resistance
Korea
Male
Mortality
Oral and Maxillofacial Surgeons*
Prevalence
Sleep Apnea, Obstructive*
Snoring